Sign In
Buy OGN
$13.56
+0 (+0%)
At Close: Aug 04, 2026
SHANGHAI, China & JERSEY CITY, N.J.--(BUSINESS WIRE)---- $OGN #denosumabbiosimilar--European Medicines Agency validates Organon and Henlius marketing authorization filings for Prolia and Xgeva (denosu
5 Relative Price Strength Stocks With Strong Return Potential
09:41am, Wednesday, 22'nd May 2024
VITL, SFM, RCL, AEM and OGN are five stocks with explosive relative price strength.
Natixis Advisors L.P. Has $396,000 Stake in Organon & Co. (NYSE:OGN)
04:54am, Monday, 20'th May 2024
Natixis Advisors L.P. reduced its stake in shares of Organon & Co. (NYSE:OGN – Free Report) by 4.5% in the 4th quarter, according to its most recent Form 13F filing with the Securities and
Is Stagflation Round the Corner? 3 Ultra-Safe Picks
09:10am, Wednesday, 15'th May 2024
Since it's becoming difficult to downplay the idea of stagflation, investors should place their bets on ultra-safe stocks such as Western Union (WU), Frontline (FRO) and Organon (OGN).
Surging Earnings Estimates Signal Upside for Organon (OGN) Stock
01:21pm, Tuesday, 14'th May 2024
Organon (OGN) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Best Value Stocks to Buy for May 13th
08:21am, Monday, 13'th May 2024
OGN, ODP and ASC made it to the Zacks Rank #1 (Strong Buy) value stocks list on May 13, 2024.
Organon Graduates From Spinoff Skepticism, With A Yield Above 5%
06:58am, Saturday, 11'th May 2024
Organon, Pfizer, and Bristol Myers all offer yields above 5% and can compete with most Treasuries, but only Organon is up YTD. Spinoffs often struggle in their initial years, but Organon's partial r
Organon Announces Pricing of $1.0 Billion Senior Notes Offering
08:20pm, Tuesday, 07'th May 2024
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN) (“Organon”), a global healthcare company with a focus on women's health, announced today that it, together with Organon Foreign Debt Co-Issu
Four Reasons Why Organon Stock Is A Good Buy
12:43pm, Tuesday, 07'th May 2024
OGN has underperformed its healthcare peers and the benchmark over the past year, but this could change going forward. The company's dominant women's health product- Nexplanon is looking at double-dig
Organon Announces Proposed $1.0 Billion Senior Notes Offering
07:58am, Tuesday, 07'th May 2024
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN) (“Organon”), a global healthcare company with a focus on women's health, announced today that it, together with Organon Foreign Debt Co-Issu
What Makes Organon (OGN) a New Buy Stock
01:01pm, Thursday, 02'nd May 2024
Organon (OGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Organon & Co. (OGN) Q1 2024 Earnings Call Transcript
11:09am, Thursday, 02'nd May 2024
Organon & Co. (NYSE:OGN ) Q1 2024 Earnings Conference Call May 2, 2024 8:30 AM ET Company Participants Jennifer Halchak - Vice President, Investor Relations Kevin Ali - Chief Executive Officer Matt Wa
Organon (OGN) Tops Q1 Earnings and Revenue Estimates
09:55am, Thursday, 02'nd May 2024
Organon (OGN) came out with quarterly earnings of $1.22 per share, beating the Zacks Consensus Estimate of $0.97 per share. This compares to earnings of $1.08 per share a year ago.
Organon Reports Results for the First Quarter Ended March 31, 2024
07:30am, Thursday, 02'nd May 2024
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon Reports Results for the First Quarter Ended March 31, 2024.
7 Sleeper Stocks to Buy Before Wall Street Wakes Up: April 2024
01:26pm, Wednesday, 01'st May 2024
Sleeper stocks to buy – based on Nasdaq.com's glossary – represent securities that offer significant price appreciation potential once its fundamentals have been recognized. That could cover a lot
